BFS
WST icon

Bradley Foster & Sargent’s West Pharmaceutical WST Stock Holding History

Bradley Foster & Sargent’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$272K Buy
+759
New +$232K ﹤0.01% 490
2026
Q1 		– Sell
-740
Closed -$204K – 543
2025
Q4 		$204K Sell
740
-41
-5% -$11.2K ﹤0.01% 521
2025
Q3 		$205K Buy
+781
New +$190K ﹤0.01% 529
2025
Q1 		– Sell
-829
Closed -$272K – 476
2024
Q4 		$272K Buy
+829
New +$261K ﹤0.01% 424
2024
Q2 		– Sell
-554
Closed -$219K – 462
2024
Q1 		$219K Buy
+554
New +$205K ﹤0.01% 425
2023
Q4 		– Sell
-779
Closed -$298K – 447
2023
Q3 		$298K Hold
779
– – 0.01% 390
2023
Q2 		$298K Sell
779
-55
-7% -$19.6K 0.01% 390
2023
Q1 		$289K Buy
+834
New +$244K 0.01% 380
2022
Q4 		– Sell
-1,709
Closed -$421K – 442
2022
Q3 		$421K Sell
1,709
-6
-0.3% -$1.83K 0.01% 333
2022
Q2 		$519K Buy
1,715
+490
+40% +$159K 0.01% 322
2022
Q1 		$503K Hold
1,225
– – 0.01% 348
2021
Q4 		$575K Sell
1,225
-25
-2% -$10.8K 0.01% 310
2021
Q3 		$531K Sell
1,250
-25
-2% -$10.5K 0.01% 297
2021
Q2 		$458K Hold
1,275
– – 0.01% 319
2021
Q1 		$359K Sell
1,275
-75
-6% -$21.5K 0.01% 322
2020
Q4 		$382K Sell
1,350
-75
-5% -$21K 0.01% 317
2020
Q3 		$392K Buy
+1,425
New +$377K 0.01% 274
2020
Q1 		$217K Sell
1,425
-100
-7% -$15.4K 0.01% 308
2019
Q4 		$229K Sell
1,525
-100
-6% -$14.6K 0.01% 341
2019
Q3 		$230K Hold
1,625
– – 0.01% 323
2019
Q2 		$203K Buy
+1,625
New +$192K 0.01% 340
2018
Q4 		– Sell
-1,700
Closed -$210K – 369
2018
Q3 		$210K Buy
+1,700
New +$191K 0.01% 353
2017
Q4 		– Sell
-2,240
Closed -$216K – 362
2017
Q3 		$216K Hold
2,240
– – 0.01% 343
2017
Q2 		$212K Buy
+2,240
New +$206K 0.01% 334

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bradley Foster & Sargent's WST Position: Q2 2026 in Review

Bradley Foster & Sargent opened a new position in West Pharmaceutical (WST) in Q2 2026: 759 shares worth $272K. The stake represents ﹤0.01% of the portfolio and ranks #490 among its holdings. This is a return to the name: Bradley Foster & Sargent previously reported a position in WST as recently as Q4 2025.

Bradley Foster & Sargent first reported a position in WST in Q2 2017 and has held it in 24 quarters since. The position peaked at $575K in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Bradley Foster & Sargent held 759 shares of West Pharmaceutical worth $272K as of Q2 2026.
  • West Pharmaceutical was a new Bradley Foster & Sargent position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Bradley Foster & Sargent's portfolio in Q2 2026, its #490 holding.
  • Bradley Foster & Sargent first reported a position in West Pharmaceutical in Q2 2017 and has held it in 24 quarters since.
  • Bradley Foster & Sargent's West Pharmaceutical position peaked at $575K in Q4 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Bradley Foster & Sargent's 13F filing for Q2 2026, filed 14 Aug 2026.